Please select the option that best describes you:

How would you approach de novo metastatic castrate sensitive prostate cancer with extensive locoregional spread causing rectal compression, retroperitoneal lymphadenopathy, and PSA > 3000 but no visceral or bone metastases?  

Would you consider adding docetaxel to ADT and novel hormonal agents?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more